000

SAMJIN PHARM

No trades
See on Supercharts
Market capitalization
‪242.37 B‬KRW
‪18.91 B‬KRW
‪292.13 B‬KRW
‪5.95 M‬
Beta (1Y)
0.35

About SAMJIN PHARM

CEO
Yong-Ju Choi
Headquarters
Seoul
Founded
1968
ISIN
KR7005500004
FIGI
BBG000BDVF73
Samjin Pharmaceutical Co., Ltd. engages in the manufacture, distribution, and sale of pharmaceutical products. Its products include tablets, capsules, and shots. The company was founded on April 18, 1968 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 005500 is 19880 KRW — it has increased by 0.40% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange SAMJIN PHARM stocks are traded under the ticker 005500.
SAMJIN PHARM is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
005500 stock is 0.61% volatile and has beta coefficient of 0.35. Check out the list of the most volatile stocks — is SAMJIN PHARM there?
Yes, you can track SAMJIN PHARM financials in yearly and quarterly reports right on TradingView.
005500 stock has risen by 1.43% compared to the previous week, the month change is a 3.73% fall, over the last year SAMJIN PHARM has showed a 12.81% decrease.
005500 net income for the last quarter is ‪7.38 B‬ KRW, while the quarter before that showed ‪3.14 B‬ KRW of net income which accounts for 134.72% change. Track more SAMJIN PHARM financial stats to get the full picture.
Today SAMJIN PHARM has the market capitalization of ‪252.94 B‬, it has increased by 0.25% over the last week.
Yes, 005500 dividends are paid annually. The last dividend per share was 800.00 KRW. As of today, Dividend Yield (TTM)% is 4.04%. Tracking SAMJIN PHARM dividends might help you take more informed decisions.
SAMJIN PHARM dividend yield was 3.70% in 2023, and payout ratio reached 54.81%. The year before the numbers were 3.12% and 46.30% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 005500 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SAMJIN PHARM stock right from TradingView charts — choose your broker and connect to your account.
005500 reached its all-time high on Sep 28, 2018 with the price of 64900 KRW, and its all-time low was 3490 KRW and was reached on May 18, 2004.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SAMJIN PHARM technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SAMJIN PHARM stock shows the sell signal. See more of SAMJIN PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SAMJIN PHARM EBITDA is ‪36.28 B‬ KRW, and current EBITDA margin is 12.70%. See more stats in SAMJIN PHARM financial statements.